secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASPEN AEROGELS INC (ASPN)
CIK:        0001145986
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001171843-25-005147
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Aspen Aerogels Reports Q2 2025 Revenue of $78M, Net Loss of $9.1M, and CFO Transition
--------------------------------------------------------------------------------

- Total revenue for Q2 2025 was $78.0 million, down from $117.8 million in Q2 2024.
- Net loss was $9.1 million, including $5.9 million of restructuring and impairment charges, compared to net income of $16.8 million a year ago.
- Adjusted EBITDA for Q2 2025 was $9.7 million, versus $28.9 million in the prior-year quarter.
- Aspen announces a CFO transition to an internal successor during Q3 2025.
- Fixed cost structure reductions are expected to drive incremental profit in the second half of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145986/000117184325005147/0001171843-25-005147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145986/000117184325005147/f8k_080725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-005147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer